Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05300048
Title Combination of Serabelisib and Insulin Suppressing Diet in Subjects With Advanced Solid Tumors With PIK3CA Mutations
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Faeth Therapeutics
Indications

endometrial adenocarcinoma

endometrial serous adenocarcinoma

endometrial carcinoma

ovarian clear cell carcinoma

rectum adenocarcinoma

endometrial squamous cell carcinoma

colon adenocarcinoma

Advanced Solid Tumor

uterine carcinosarcoma

endometrioid ovary carcinoma

endometrial transitional cell carcinoma

endometrial clear cell adenocarcinoma

Therapies

Serabelisib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST